Abstract 2532: integrated therapeutic antibody development at the National Research Council of Canada

Download
  1. Get@NRC: Abstract 2532: integrated therapeutic antibody development at the National Research Council of Canada (Opens in a new window)
DOIResolve DOI: http://doi.org/10.1158/1538-7445.AM2012-2532
AuthorSearch for: ; Search for:
TypeArticle
Journal titleCancer Research
ISSN0008-5472
1538-7445
Volume72
Issue8 Supplement
Pages25322532
Abstract
Publication date
PublisherAmerican Association for Cancer Research
LanguageEnglish
AffiliationHuman Health Therapeutics; National Research Council Canada
Peer reviewedYes
NPARC number23001785
Export citationExport as RIS
Report a correctionReport a correction
Record identifier43e3adb3-7a37-4997-8810-9a01dd13295c
Record created2017-04-06
Record modified2017-04-06
Bookmark and share
  • Share this page with Facebook (Opens in a new window)
  • Share this page with Twitter (Opens in a new window)
  • Share this page with Google+ (Opens in a new window)
Date modified: